Page last updated: 2024-09-03
4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol and quinine
4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol has been researched along with quinine in 1 studies
Compound Research Comparison
Studies (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Trials (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Recent Studies (post-2010) (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Studies (quinine) | Trials (quinine) | Recent Studies (post-2010) (quinine) |
---|---|---|---|---|---|
70 | 12 | 9 | 6,859 | 398 | 1,099 |
Protein Interaction Comparison
Protein | Taxonomy | 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol (IC50) | quinine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.28 | |
Solute carrier family 22 member 2 | Mus musculus (house mouse) | 2.8 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 3.85 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.7 | |
Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 0.094 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.6285 | |
Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 2.0333 | |
Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | 1.7 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Inaba, T; Kalow, W; Tyndale, RF | 1 |
Other Studies
1 other study(ies) available for 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol and quinine
Article | Year |
---|---|
Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Haloperidol; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Quinidine; Quinine | 1991 |